UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 31, 2021
Accession Number:
0001193125-21-098129
Submission Type:
POS AM
CIK:
0001740547
Company Name:
Urovant Sciences Ltd.
File Number:
333-234620